Skip to main content

Find Clinical Trials

Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

NCT00361140

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +16 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

NCT02125318

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +21 more
Locations: East Valley Hematology and Oncology Medical Group Burbank, California, United States

California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States

California Cancer Associates for Research & Excellence (cCARE) Escondido, California, United States

California Cancer Associates For Research and Excellence Fresno, California, United States

View Trial Details

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 326 locations

View Trial Details

Completed

Primary Thrombocythaemia 1 Trial

NCT00175838

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +12 more
Locations: Addenbrooke's Hospital Cambridge, Cambs, United Kingdom

View Trial Details

Completed

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00104975

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +58 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00683046

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +41 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

NCT02084563

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +29 more
Locations: Hospital Israelita Albert Einstein São Paulo, Brazil

View Trial Details

Completed

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

NCT00072475

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States

CCOP - Christiana Care Health Services Newark, Delaware, United States

Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States

Ella Milbank Foshay Cancer Center at Jupiter Medical Center Jupiter, Florida, United States

View all 68 locations

View Trial Details

Completed

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

NCT00533923

Conditions: ALL, AML, Anemia, +34 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

NCT00003600

Conditions: Anemia, Blood Protein Disorders, Bone Marrow Diseases, +39 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

Howard University Cancer Center Washington D.C., District of Columbia, United States

CCOP - Illinois Oncology Research Association Peoria, Illinois, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

View all 21 locations

View Trial Details